About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Elephantiasis Could Be Wiped Out by 2020

by Gopalan on October 10, 2008 at 9:35 AM
 Elephantiasis Could Be Wiped Out by 2020

Elephantiasis, the painful and disfiguring disease affecting more than 100 million people worldwide, could be wiped out by 2020, experts believe.

Lymphatic filariasis (LF), often called elephantiasis, is caused by parasitic worms and causes grotesque swelling of the limbs, breasts and genitals.

Advertisement

A World Health Organisation-sponsored drive has delivered 1.9 billion doses of a simple cure since 2000.

Pharmaceutical firms have offered drugs free, keeping costs minimal. The success of the programme was highlighted in a paper in the Public Library of Science Neglected Tropical Diseases journal.
Advertisement

The Global Programme to Eliminate LF has so far prevented an estimated 6.6 million children from catching the condition, and stopped it from progressing in another 9.5 million people who already have it.

It is thought to be the most rapidly expanding drug administration programme in public health history.

Professor David Molyneux, from the Liverpool School of Hygiene and Tropical Medicine, and the Executive Secretary of the campaign, said that the success of the project was "staggering".

"In some countries we are talking about costs of five pence per person, per year.

"We are reaching hundreds of millions of the world's poorest people, and it's the additional benefits these drugs bring which are really important.

"I think that compared to most other public health programmes, it's going remarkably well."

Dr Mwele Malecela, who chairs the programme, said: "We are on track to accomplish our goal of elimination by 2020.

"When we do, this programme will be a leading case study for how to scale up disease elimination programmes globally".

There are 83 countries in the world where the disease is endemic, and the programme has so far administered treatments in 48 of them, to more than 570 million people.

The scale of the challenge is immense - approximately one fifth of the world's population, or 1.3 billion people, is said to be "at risk" of contracting LF, BBC reports.

The treatment uses a combination of two drugs, both donated free of charge from GlaxoSmithKline and Merck and Co.

These need to be given once a year for five years to ensure that the disease does not spread.

Another benefit of the drugs is that they also tackle intestinal worms, and approximately 100 million children and women have been treated for these.



Source: Medindia
GPL/V
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Tropical Disease News

Rare Zika Case Emerges in Cambodia After Seven Years
The Ministry of Health (MoH) in Cambodia has reported the first Zika virus case in the country since 2016.
Global Spread of Mpox Virus Persists: Cases Reported in China and Thailand
The WHO has assessed the risk of monkeypox for the general population in countries not previously impacted by the current outbreak as low.
Understanding Nipah Virus: Droplet Transmission and Its Lethality at 40-70%
Nipah is a zoonotic virus, meaning it can be transmitted from animals to humans. Fruit bats serve as the natural reservoirs for Nipah virus.
Tamil Nadu Reports Zero Nipah Virus Cases
Nipah Virus (NiV) or Hendra virus is a deadly virus that spreads via contact with the saliva, urine, or excreta of fruit bats or pigs.
Nipah Virus Outbreak: 2 Fatalities Trigger Emergency Response in Kozhikode
Nipah virus is mainly a zoonotic disease, transferring from animals to humans, and can also spread via contaminated food or contact with infected individuals.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Elephantiasis Could Be Wiped Out by 2020 Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests